risks of glp-1 Overdose increase as demand for injectable weight-loss drugs on the rise, research finds Benefit-Risk Assessment of GLP-1 Receptor

Billings, MD, MMSc The next steps involve launching Phase 3 clinical trials, which will study eloralintide in a much larger and more diverse group of participants to further examine eloralintides effectiveness and long-term safety, she added

Last updated: July 16, 2026 Medically reviewed by Dr

Many women struggle with weight loss not just because of eating habits, but due to thyroid dysfunction, insulin resistance, or hormonal imbalances that need to be addressed alongside GLP-1/GIP therapy

Signs that you need more than fiber If you have been taking an appropriate fiber supplement at full dose with adequate hydration for 2 or more weeks and you are still experiencing fewer than 3 bowel movements per week, straining with most bowel movements, hard or lumpy stool consistently, or abdominal pain associated with constipation, fiber alone is not going to solve the problem

Our personalized care approach ensures you get the most from your semaglutide treatment